VKH
PDLI

Virtu KCG Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Virtu KCG Holdings’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$104K Sell
41,972
-30,175
-42% -$69.4K ﹤0.01% 2407
2017
Q1 		$164K Buy
72,147
+21,382
+42% +$47.3K ﹤0.01% 2523
2016
Q4 		$108K Buy
50,765
+19,665
+63% +$54.9K ﹤0.01% 2890
2016
Q3 		$104K Buy
+31,100
New +$98.7K ﹤0.01% 2626
2016
Q2 		– Sell
-20,130
Closed -$67K – 3680
2016
Q1 		$67K Sell
20,130
-104,224
-84% -$325K ﹤0.01% 2402
2015
Q4 		$440K Buy
124,354
+105,643
+565% +$442K 0.01% 1701
2015
Q3 		$94K Sell
18,711
-27,702
-60% -$159K ﹤0.01% 2848
2015
Q2 		$298K Buy
+46,413
New +$311K 0.01% 2079
2015
Q1 		– Sell
-43,061
Closed -$332K – 4488
2014
Q4 		$332K Buy
43,061
+953
+2% +$7.54K 0.01% 2211
2014
Q3 		$315K Sell
42,108
-3,046
-7% -$28.3K 0.01% 2303
2014
Q2 		$436K Buy
45,154
+6,558
+17% +$58.4K 0.01% 2097
2014
Q1 		$320K Buy
38,596
+23,077
+149% +$198K ﹤0.01% 2445
2013
Q4 		$131K Sell
15,519
-105,568
-87% -$890K ﹤0.01% 3347
2013
Q3 		$965K Buy
+121,087
New +$973K 0.01% 1201

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Virtu KCG Holdings's PDLI Position: Q2 2017 in Review

Virtu KCG Holdings reduced its PDL BioPharma, Inc. (PDLI) stake by 42% in Q2 2017, selling an estimated $69.4K and leaving 41,972 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Virtu KCG Holdings first reported a position in PDLI in Q3 2013 and has held it in 14 quarters since. The position peaked at $965K in Q3 2013. 171 funds tracked by Wall St. Rank hold PDLI as of Q2 2017.

  • Virtu KCG Holdings held 41,972 shares of PDL BioPharma, Inc. worth $104K as of Q2 2017.
  • Virtu KCG Holdings sold 30,175 PDL BioPharma, Inc. shares in Q2 2017, an estimated $69.4K.
  • PDL BioPharma, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2407 holding.
  • Virtu KCG Holdings first reported a position in PDL BioPharma, Inc. in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's PDL BioPharma, Inc. position peaked at $965K in Q3 2013.
  • 171 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.